<DOC>
	<DOCNO>NCT01228344</DOCNO>
	<brief_summary>The purpose study describe pediatric adult patient ( U.S. foreign resident ) diagnose malaria treat artemether-lumefantrine regard demographic , include evaluation malaria immune status , treatment effectiveness , prior concomitant medication use , occurrence adverse event association artemether-lumefantrine treatment , base information collect CDC Malaria Case Surveillance Report Form .</brief_summary>
	<brief_title>Surveillance Effectiveness/Safety Artemether-lumefantrine Patients With Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>Any male female infant , child adult patient diagnose malaria receive artemetherlumefantrine report CDC . Malaria may clinically suspect confirm ( microscopically , and/or polymerase chain reaction [ PCR ] , and/or rapid diagnostic test [ RDT ] ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Artemether-lumefantrine</keyword>
	<keyword>demographic</keyword>
	<keyword>malaria</keyword>
</DOC>